Selleck Chemicals supplies over 3,000 inhibitors used in the study of cell signaling pathways. We actively tracks the latest science so our customers can rely on us to be the leading supplier of the newest inhibitors.
Company WebsiteAnidulafungin, an echinocandin derivative, inhibits glucan synthase activity, used as an antifungal drug.
More Information Supplier PageAnidulafungin, an echinocandin derivative, inhibits glucan synthase activity, used as an antifungal drug.
More Information Supplier PageAnidulafungin, an echinocandin derivative, inhibits glucan synthase activity, used as an antifungal drug.
More Information Supplier PageAnifrolumab (Anti-IFNAR1) is a human monoclonal antibody. It is a type I interferon (IFN) receptor antagonist, that blocks the activity of type I interferon. Anifrolumab can be used in research of systemic lupus erythematosus (SLE). MW: 145.5 KD.
More Information Supplier PageAnifrolumab (Anti-IFNAR1) is a human monoclonal antibody. It is a type I interferon (IFN) receptor antagonist, that blocks the activity of type I interferon. Anifrolumab can be used in research of systemic lupus erythematosus (SLE). MW: 145.5 KD.
More Information Supplier PageAnifrolumab (Anti-IFNAR1) is a human monoclonal antibody. It is a type I interferon (IFN) receptor antagonist, that blocks the activity of type I interferon. Anifrolumab can be used in research of systemic lupus erythematosus (SLE). MW: 145.5 KD.
More Information Supplier PageAnisodamine (6-Hydroxyhyoscyamine) is a naturally occurring atropine derivative and exhibits anti-inflammatory activity. It also inhibits α1-adrenergic receptors and muscarinic acetylcholine receptors (mAChRs).
More Information Supplier PageAnisole is a flavouring agent that is a precursor to perfumes, insect pheromones, and pharmaceuticals.This product is a hazardous chemical (acute toxicity/flammable/skin corrosive). Please use it while wearing a protective face mask, gloves, and clothing.
More Information Supplier PageAnisomycin (Flagecidin, Wuningmeisu C) is a bacterial antibiotic isolated from Streptomyces griseolus, which inhibits protein synthesis, and also act as a JNK activator. Anisomycin upregulates autophagy and increases apoptosis.
More Information Supplier PageAnisomycin (Flagecidin, Wuningmeisu C) is a bacterial antibiotic isolated from Streptomyces griseolus, which inhibits protein synthesis, and also act as a JNK activator. Anisomycin upregulates autophagy and increases apoptosis.
More Information Supplier PageAnisomycin (Flagecidin, Wuningmeisu C) is a bacterial antibiotic isolated from Streptomyces griseolus, which inhibits protein synthesis, and also act as a JNK activator. Anisomycin upregulates autophagy and increases apoptosis.
More Information Supplier PageAnisomycin (Flagecidin, Wuningmeisu C) is a bacterial antibiotic isolated from Streptomyces griseolus, which inhibits protein synthesis, and also act as a JNK activator. Anisomycin upregulates autophagy and increases apoptosis.
More Information Supplier PageAnisomycin (Flagecidin, Wuningmeisu C) is a bacterial antibiotic isolated from Streptomyces griseolus, which inhibits protein synthesis, and also act as a JNK activator. Anisomycin upregulates autophagy and increases apoptosis.
More Information Supplier PageAnle138b is a novel oligomer modulator and an aggregation inhibitor, blocking the formation of pathological aggregates of prion protein (PrP(Sc)) and of α-synuclein (α-syn) with good oral bioavailability, blood-brain-barrier penetration and no detectable toxicity. Anle138b shows a new approach for disease-modifying therapy in neurodegenerative diseases such as prion and Parkinson’s disease.
More Information Supplier PageAnlotinib (AL3818) is a highly potent and selective VEGFR2 inhibitor with IC50 less than 1 nM. It has broad-spectrum antitumor potential in clinical trials. Please use saline solution rather than PBS for dilutions. PBS may cause precipitation.
More Information Supplier PageAnlotinib (AL3818) is a highly potent and selective VEGFR2 inhibitor with IC50 less than 1 nM. It has broad-spectrum antitumor potential in clinical trials. Please use saline solution rather than PBS for dilutions. PBS may cause precipitation.
More Information Supplier PageAnlotinib (AL3818) is a highly potent and selective VEGFR2 inhibitor with IC50 less than 1 nM. It has broad-spectrum antitumor potential in clinical trials. Please use saline solution rather than PBS for dilutions. PBS may cause precipitation.
More Information Supplier PageAnlotinib (AL3818) is a highly potent and selective VEGFR2 inhibitor with IC50 less than 1 nM. It has broad-spectrum antitumor potential in clinical trials. Please use saline solution rather than PBS for dilutions. PBS may cause precipitation.
More Information Supplier PageAnona Squamosa Leaf Extract is extracted from the leaf of Anona Squamosa, which has anticancer activities against cervical cancer.
More Information Supplier PageAnrukinzumab (Anti-IL-13) is a humanized monoclonal antibody targeting IL-13. It reduces lung inflammation and can be used in studies of ulcerative colitis (UC) as well as asthma. MW :150 KD.
More Information Supplier PageAnrukinzumab (Anti-IL-13) is a humanized monoclonal antibody targeting IL-13. It reduces lung inflammation and can be used in studies of ulcerative colitis (UC) as well as asthma. MW :150 KD.
More Information Supplier PageAnrukinzumab (Anti-IL-13) is a humanized monoclonal antibody targeting IL-13. It reduces lung inflammation and can be used in studies of ulcerative colitis (UC) as well as asthma. MW :150 KD.
More Information Supplier PageAnsamitocin p-3 (Maytansinol isobutyrate, NSC292222, Antibiotic C 15003P3) is a potent inhibitor of tubulin polymerization with IC50 of 3.4 μM.
More Information Supplier PageAnserine (β-alanyl-N-methylhistidine) is a dipeptide containing β-alanine and 1-methylhistidine. It is normally absent from human tissues and body fluids, and its appearance there is an artifact of diet and serum carnosinase deficiency.
More Information Supplier PageAnserine (β-alanyl-N-methylhistidine) is a dipeptide containing β-alanine and 1-methylhistidine. It is normally absent from human tissues and body fluids, and its appearance there is an artifact of diet and serum carnosinase deficiency.
More Information Supplier PageAnsofaxine hydrochloride (LY03005, LPM570065), a triple reuptake inhibitor, inhibits serotonin, dopamine and norepinephrine reuptake with IC50 values of 723, 491 and 763 nM, respectively.
More Information Supplier PageAntazoline Phosphate is the phosphate salt of antazoline. Antazoline is a first-generation antihistaminic agent and acts as a histamine H1 receptor antagonist.
More Information Supplier PageAnthraquinone-2-carboxylic Acid is a novel electron shuttling mediator, showing potent anti-inflammatory and antinociceptive activities in vivo.
More Information Supplier PageAnti- FcRL5 / IRTA2 / CD307e (DFRF4539A) is a monoclonal antibody directed against Fc receptor homolog 5 (FcRH5, IFGP5, BXMAS1, CD307, IRTA2) with potential antineoplastic activity. MW: 144.68 KD.
More Information Supplier PageAnti- FcRL5 / IRTA2 / CD307e (DFRF4539A) is a monoclonal antibody directed against Fc receptor homolog 5 (FcRH5, IFGP5, BXMAS1, CD307, IRTA2) with potential antineoplastic activity. MW: 144.68 KD.
More Information Supplier PageAnti- FcRL5 / IRTA2 / CD307e (DFRF4539A) is a monoclonal antibody directed against Fc receptor homolog 5 (FcRH5, IFGP5, BXMAS1, CD307, IRTA2) with potential antineoplastic activity. MW: 144.68 KD.
More Information Supplier PageAnti-158P1D7 is a monoclonal anti-158P1D7 antibody used in the production of antibody drug conjugates (adc) that bind to 158P1D7 proteins. MW: 146.0 KD.
More Information Supplier PageAnti-158P1D7 is a monoclonal anti-158P1D7 antibody used in the production of antibody drug conjugates (adc) that bind to 158P1D7 proteins. MW: 146.0 KD.
More Information Supplier PageAnti-158P1D7 is a monoclonal anti-158P1D7 antibody used in the production of antibody drug conjugates (adc) that bind to 158P1D7 proteins. MW: 146.0 KD.
More Information Supplier PageAnti-AA2AR / Adenosine A2aR (3F6-9G5) is a monoclonal antibody targeting A2A adenosine receptor. It may be an attractive target for research studies or treatments of insomnia, pain, depression, and Parkinson’s disease. MW :146.66 KD.
More Information Supplier PageAnti-AA2AR / Adenosine A2aR (3F6-9G5) is a monoclonal antibody targeting A2A adenosine receptor. It may be an attractive target for research studies or treatments of insomnia, pain, depression, and Parkinson’s disease. MW :146.66 KD.
More Information Supplier PageAnti-AA2AR / Adenosine A2aR (3F6-9G5) is a monoclonal antibody targeting A2A adenosine receptor. It may be an attractive target for research studies or treatments of insomnia, pain, depression, and Parkinson’s disease. MW :146.66 KD.
More Information Supplier PageAnti-ABCB5 is a monoclonal antibody (mAb) against ABCB5 (ATP-binding cassette transporter, sub-family B (MDR/TAP), member 5) with the potential to be used in research on melanoma. MW: 147.74 KD.
More Information Supplier PageAnti-ABCB5 is a monoclonal antibody (mAb) against ABCB5 (ATP-binding cassette transporter, sub-family B (MDR/TAP), member 5) with the potential to be used in research on melanoma. MW: 147.74 KD.
More Information Supplier PageAnti-ABCB5 is a monoclonal antibody (mAb) against ABCB5 (ATP-binding cassette transporter, sub-family B (MDR/TAP), member 5) with the potential to be used in research on melanoma. MW: 147.74 KD.
More Information Supplier PageAnti-ACVR1 / ALK-2 (DS-6016a) monoclonal antibody targeting ALK-2. It can be used in the treatment of fibrodysplasia ossificans progressiva (FOP). MW :145.56.
More Information Supplier PageAnti-ACVR1 / ALK-2 (DS-6016a) monoclonal antibody targeting ALK-2. It can be used in the treatment of fibrodysplasia ossificans progressiva (FOP). MW :145.56.
More Information Supplier PageAnti-ACVR1 / ALK-2 (DS-6016a) monoclonal antibody targeting ALK-2. It can be used in the treatment of fibrodysplasia ossificans progressiva (FOP). MW :145.56.
More Information Supplier PageAnti-ACVR2A (Ab-14E1) is rabbit polyclonal antibody targeting human ACVR2A. It can be used in research of human intestinal cancer and preeclampsia. MW :146.36 KD.
More Information Supplier PageAnti-ACVR2A (Ab-14E1) is rabbit polyclonal antibody targeting human ACVR2A. It can be used in research of human intestinal cancer and preeclampsia. MW :146.36 KD.
More Information Supplier PageAnti-ACVR2A (Ab-14E1) is rabbit polyclonal antibody targeting human ACVR2A. It can be used in research of human intestinal cancer and preeclampsia. MW :146.36 KD.
More Information Supplier PageAnti-ADAM9 (Imgc936) is a humanized antibody targeting the ADAM metallopeptidase domain 9 (ADAM9). It is a therapeutic candidate for the treatment of various cancers including non-small cell lung, pancreatic, gastric, breast, ovarian, and colorectal cancer. MW :147.66 KD.
More Information Supplier PageAnti-ADAM9 (Imgc936) is a humanized antibody targeting the ADAM metallopeptidase domain 9 (ADAM9). It is a therapeutic candidate for the treatment of various cancers including non-small cell lung, pancreatic, gastric, breast, ovarian, and colorectal cancer. MW :147.66 KD.
More Information Supplier PageAnti-ADAM9 (Imgc936) is a humanized antibody targeting the ADAM metallopeptidase domain 9 (ADAM9). It is a therapeutic candidate for the treatment of various cancers including non-small cell lung, pancreatic, gastric, breast, ovarian, and colorectal cancer. MW :147.66 KD.
More Information Supplier Page
